• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非小细胞肺癌患者肿瘤组织中Foxp3的表达显著高于正常组织,尤其是在直径小于30毫米的肿瘤中。

Expression of Foxp3 in non-small cell lung cancer patients is significantly higher in tumor tissues than in normal tissues, especially in tumors smaller than 30 mm.

作者信息

Ishibashi Yasunori, Tanaka Shigebumi, Tajima Kohei, Yoshida Takeshi, Kuwano Hiroyuki

机构信息

Department of General Surgical Science and 21st Century COE Program, Gunma University Graduate School of Medicine, Maebashi, Gunma 371-8511, Japan.

出版信息

Oncol Rep. 2006 May;15(5):1315-9.

PMID:16596204
Abstract

Active suppression by CD4+CD25+ T regulatory cells (T regs) plays an important role in the down-regulation of T cell responses to foreign and self-antigens. Thus far, the potential role of T regs in human tumors has been reported. T reg-mediated suppression of antitumor immune responses may partly explain the poor clinical response to vaccine-based immunotherapy for human cancer. The forkhead transcription factor Foxp3 is a critical regulator of T regs development and function. Foxp3 represents a specific marker for the T regs. In this study, we measured the Foxp3 mRNA expression in tumors and in normal tissues from 46 patients with non-small cell lung carcinoma (NSCLC), and tumor tissues showed a significantly higher expression of Foxp3 mRNA than normal tissues. The expression of Foxp3 mRNA and the tumor diameter were inversely proportional. These results suggest that T regs expressing Foxp3 selectively accumulate in tumor tissues of NSCLC and contribute to antitumor immune dysfunction, especially in the early stages.

摘要

CD4+CD25+调节性T细胞(Tregs)的主动抑制在下调T细胞对外源和自身抗原的反应中起重要作用。迄今为止,Tregs在人类肿瘤中的潜在作用已有报道。Tregs介导的抗肿瘤免疫反应抑制可能部分解释了人类癌症基于疫苗的免疫治疗临床反应不佳的原因。叉头转录因子Foxp3是Tregs发育和功能的关键调节因子。Foxp3是Tregs的特异性标志物。在本研究中,我们检测了46例非小细胞肺癌(NSCLC)患者肿瘤组织和正常组织中Foxp3 mRNA的表达,肿瘤组织中Foxp3 mRNA的表达明显高于正常组织。Foxp3 mRNA的表达与肿瘤直径呈负相关。这些结果表明,表达Foxp3的Tregs选择性地积聚在NSCLC肿瘤组织中,并导致抗肿瘤免疫功能障碍,尤其是在早期阶段。

相似文献

1
Expression of Foxp3 in non-small cell lung cancer patients is significantly higher in tumor tissues than in normal tissues, especially in tumors smaller than 30 mm.非小细胞肺癌患者肿瘤组织中Foxp3的表达显著高于正常组织,尤其是在直径小于30毫米的肿瘤中。
Oncol Rep. 2006 May;15(5):1315-9.
2
Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease.在移植物抗宿主病患者中,体外光化学疗法伴随着循环中CD4+CD25+GITR+Foxp3+CD62L+功能性调节性T细胞水平的升高。
Transplantation. 2007 Jul 15;84(1):31-9. doi: 10.1097/01.tp.0000267785.52567.9c.
3
Increase of CD4+ CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma.肝细胞癌患者肝脏中CD4+ CD25+调节性T细胞增加。
J Hepatol. 2006 Aug;45(2):254-62. doi: 10.1016/j.jhep.2006.01.036. Epub 2006 Mar 9.
4
Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome.色素上皮衍生因子在非小细胞肺癌中的表达降低,并与临床预后相关。
Int J Mol Med. 2006 May;17(5):937-44.
5
Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner.肿瘤浸润调节性 T 细胞中 Foxp3 的高表达抑制 T 细胞增殖,并以 COX-2 依赖的方式促进胃癌的进展。
Clin Immunol. 2010 Mar;134(3):277-88. doi: 10.1016/j.clim.2009.10.005. Epub 2009 Nov 8.
6
Quantitative reverse transcription-polymerase chain reaction measurement of HASH1 (ASCL1), a marker for small cell lung carcinomas with neuroendocrine features.定量逆转录-聚合酶链反应检测HASH1(ASCL1),一种具有神经内分泌特征的小细胞肺癌标志物。
Clin Cancer Res. 2002 Apr;8(4):1082-6.
7
Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.Pokemon在非小细胞肺癌中的过表达及其对肿瘤生物学行为和临床结果的预示作用。
Lung Cancer. 2008 Oct;62(1):113-9. doi: 10.1016/j.lungcan.2008.02.014. Epub 2008 Jun 11.
8
[Clinical significance of CD4+ CD25+ regulatory T-cells detection in tumor-draining lymph nodes of nonsmall cell lung cancer patients].非小细胞肺癌患者肿瘤引流淋巴结中CD4+CD25+调节性T细胞检测的临床意义
Zhonghua Zhong Liu Za Zhi. 2007 Dec;29(12):922-6.
9
Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.XPC信使核糖核酸水平降低可能预示非小细胞肺癌患者预后不良。
Cancer. 2007 Jul 1;110(1):215-23. doi: 10.1002/cncr.22743.
10
Down-regulation of Gadd45 expression is associated with tumor differentiation in non-small cell lung cancer.Gadd45表达下调与非小细胞肺癌的肿瘤分化相关。
Anticancer Res. 2006 May-Jun;26(3A):2143-7.

引用本文的文献

1
T lymphocyte heterogeneity in NSCLC: implications for biomarker development and therapeutic innovation.非小细胞肺癌中的T淋巴细胞异质性:对生物标志物开发和治疗创新的影响。
Front Immunol. 2025 May 29;16:1604310. doi: 10.3389/fimmu.2025.1604310. eCollection 2025.
2
A positive feedback loop formed by NGFR and FOXP3 contributes to the resistance of non-small cell lung cancer to icotinib.由NGFR和FOXP3形成的正反馈回路导致非小细胞肺癌对埃克替尼产生耐药性。
Transl Cancer Res. 2020 Feb;9(2):1044-1052. doi: 10.21037/tcr.2019.12.60.
3
Immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancer.
基于单细胞技术定义的免疫结构用于癌症的预后预测和免疫治疗指导。
Cancer Commun (Lond). 2019 Apr 18;39(1):21. doi: 10.1186/s40880-019-0365-9.
4
Factors influencing recurrence following anatomic lung resection for clinical stage I non-small cell lung cancer.解剖性肺切除术治疗Ⅰ期非小细胞肺癌术后复发的影响因素。
Lung Cancer. 2019 Feb;128:145-151. doi: 10.1016/j.lungcan.2018.12.026. Epub 2018 Dec 26.
5
PD-L1 and Tumor Infiltrating Lymphocytes as Prognostic Markers in Resected NSCLC.程序性死亡配体1(PD-L1)与肿瘤浸润淋巴细胞作为可切除非小细胞肺癌的预后标志物
PLoS One. 2016 Apr 22;11(4):e0153954. doi: 10.1371/journal.pone.0153954. eCollection 2016.
6
Investigation of FOXP3 genetic variations at positions -2383 C/T and IVS9+459 T/C in southern Iranian patients with lung carcinoma.伊朗南部肺癌患者中FOXP3基因-2383 C/T和IVS9+459 T/C位点的遗传变异研究。
Iran J Basic Med Sci. 2015 May;18(5):465-71.
7
FOXP4 modulates tumor growth and independently associates with miR-138 in non-small cell lung cancer cells.FOXP4调节肿瘤生长,并在非小细胞肺癌细胞中与miR-138独立相关。
Tumour Biol. 2015 Sep;36(10):8185-91. doi: 10.1007/s13277-015-3498-8. Epub 2015 May 21.
8
Prognostic value of peripheral and local forkhead box P3 regulatory T cells in patients with non-small-cell lung cancer.外周血及局部组织中叉头框蛋白P3调节性T细胞在非小细胞肺癌患者中的预后价值
Mol Clin Oncol. 2014 Sep;2(5):685-694. doi: 10.3892/mco.2014.299. Epub 2014 May 29.
9
Clinical evaluation of systemic and local immune responses in cancer: time for integration.癌症全身和局部免疫反应的临床评估:整合的时机。
Cancer Immunol Immunother. 2014 Jan;63(1):45-57. doi: 10.1007/s00262-013-1480-0. Epub 2013 Oct 8.
10
Tumor-infiltrating lymphocytes predict response to chemotherapy in patients with advance non-small cell lung cancer.肿瘤浸润淋巴细胞预测晚期非小细胞肺癌患者对化疗的反应。
Cancer Immunol Immunother. 2012 Oct;61(10):1849-56. doi: 10.1007/s00262-012-1231-7. Epub 2012 Mar 29.